Important role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus
- PMID: 21567079
- DOI: 10.3892/ijo.2011.1033
Important role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus
Abstract
Newcastle disease virus (NDV) is an interesting agent for activating innate immune activity in macrophages including secretion of TNF-α and IFN-α, upregulation of TRAIL and activation of NF-κB and iNOS. However, the molecular mechanism of such cellular activities remains largely unknown. Tumor selectivity of replication of NDV has been described to be linked to deviations in tumor cells of the type I interferon response. We therefore focused on the interferon response to NDV of macrophages as part of innate anti-viral and anti-tumor activity. In particular, we investigated the functional significance of the interferon regulatory factor genes (IRF)-3 and IRF-7. Deletion of the IRF-3 or IRF-7 gene was found to increase susceptibility of mouse macrophages to virus infection. Surprisingly, NDV replicated better in IRF-3 KO than in IRF-7 KO macrophages. Further analysis showed that IRF-3 KO macrophages have a lower basal and NDV-induced RIG-I expression in comparison to IRF-7 KO macrophages. This might explain why, in IRF-3 KO macrophages, the secretion of type I interferons after NDV infection is delayed, when compared to IRF-7 KO and wild-type macrophages. In addition, IRF-3 KO cells showed reduced NDV-induced levels of IRF-7. This effect could be prevented by priming the cells first by interferon-α. Further results indicated that an early production of type I interferon rather than high maximal levels at later time points are important for resistance to infection by NDV. In conclusion, these results demonstrate an important role of IRF-3 for the innate anti-viral response to NDV of mouse macrophages.
Similar articles
-
Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages.Biochem Pharmacol. 2006 Nov 30;72(11):1469-76. doi: 10.1016/j.bcp.2006.06.002. Epub 2006 Jul 17. Biochem Pharmacol. 2006. PMID: 16846591 Review.
-
IRF-3-dependent and augmented target genes during viral infection.Genes Immun. 2008 Mar;9(2):168-75. doi: 10.1038/sj.gene.6364449. Epub 2007 Dec 20. Genes Immun. 2008. PMID: 18094709
-
PACT, a double-stranded RNA binding protein acts as a positive regulator for type I interferon gene induced by Newcastle disease virus.Biochem Biophys Res Commun. 2001 Mar 30;282(2):515-23. doi: 10.1006/bbrc.2001.4606. Biochem Biophys Res Commun. 2001. PMID: 11401490
-
Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.Cell. 1993 Oct 8;75(1):83-97. Cell. 1993. PMID: 8402903
-
HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion.Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):255-70. doi: 10.1016/j.cytogfr.2012.06.001. Epub 2012 Jun 27. Cytokine Growth Factor Rev. 2012. PMID: 22748237 Review.
Cited by
-
Antiviral Effects of Novel Herbal Medicine KIOM-C, on Diverse Viruses.PLoS One. 2015 May 5;10(5):e0125357. doi: 10.1371/journal.pone.0125357. eCollection 2015. PLoS One. 2015. PMID: 25942440 Free PMC article.
-
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.Future Microbiol. 2012 Mar;7(3):347-67. doi: 10.2217/fmb.12.4. Future Microbiol. 2012. PMID: 22393889 Free PMC article. Review.
-
Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review).Oncol Lett. 2015 Feb;9(2):527-534. doi: 10.3892/ol.2014.2727. Epub 2014 Nov 21. Oncol Lett. 2015. PMID: 25624883 Free PMC article.
-
Interferon-mediated antiviral activities of Angelica tenuissima Nakai and its active components.J Microbiol. 2016 Jan;54(1):57-70. doi: 10.1007/s12275-016-5555-4. Epub 2016 Jan 5. J Microbiol. 2016. Retraction in: J Microbiol. 2018 Sep;56(9):690. doi: 10.1007/s12275-018-0579-6. PMID: 26727903 Free PMC article. Retracted.
-
ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.Oncotarget. 2016 Nov 8;7(45):74393-74409. doi: 10.18632/oncotarget.11911. Oncotarget. 2016. PMID: 27626310 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials